Ocean Biomedical (OCEA) Stock Price

Ocean Biomedical Price

NASDAQ·CLOSED
0.00
​
Market closed

Ocean Biomedical stock price

Access this data via the Eulerpool API

Ocean Biomedical business model & stock analysis

Ocean Biomedical, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York. The company went IPO on 2021-09-15. The firm is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The firm helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). The company offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.

Frequently asked questions about Ocean Biomedical

7 analysts currently rate the Ocean Biomedical stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Ocean Biomedical share trades at 0.00 EUR (0.00 USD).

The Ocean Biomedical share (OCEA) is listed on 2 stock exchanges, including: NASDAQ (OCEA), Frankfurt (8AW0.F).

The revenue cannot currently be calculated for Ocean Biomedical.

The profit cannot currently be calculated for Ocean Biomedical.

The P/E ratio cannot be calculated for Ocean Biomedical at the moment.

The P/S cannot be calculated for Ocean Biomedical currently.

The Eulerpool Quality Score for Ocean Biomedical is 2/10.

The ISIN of Ocean Biomedical is US67644C1045. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Ocean Biomedical is A3D2GJ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Ocean Biomedical is OCEA. The ticker symbol is used to trade Ocean Biomedical shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Sep 15, 2021
ISIN
US67644C1045
Cusip
67644C104
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.66 %
Last updated Oct 10, 2026, 3:41 PM

Ocean Biomedical Peer Group

Ocean Biomedical Ticker

FRANKFURT · 8AW0.FNASDAQ · OCEA

Ocean Biomedical FIGI

OCEA:US · BBG011WXCRR6OCEA:UA · BBG0132TM010OCEA:UC · BBG0132TM029OCEA:UN · BBG0132TM047OCEA:UP · BBG0132TM056OCEA:UB · BBG0132TM074OCEA:UM · BBG0132TM092OCEA:UX · BBG0132TM0B9OCEA:UR · BBG0132TM0C8OCEA:UD · BBG0132TM0H3OCEA:UF · BBG0132TM0L8OCEA:VY · BBG0132TM0M7